Wolverine Trading, LLC Rocket Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $303,456 - $356,584	-11,600 Reduced 59.49%	7,900 $212,000
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $125,850 - $239,550	-7,500 Reduced 27.78%	19,500 $584,000
Q3 2023 Nov 15, 2023	BUY	$15.07 - $24.05 $406,890 - $649,350	27,000 New	27,000 $553,000
Q3 2021 Nov 12, 2021	SELL	$27.42 - $48.97 $216,618 - $386,863	-7,900 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$39.41 - $47.25 $311,339 - $373,275	7,900 New	7,900 $342,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $890M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.